Aeterna Zentaris names Leslie Auld as CFO
Aeterna Zentaris (NASDAQ, TSX:AEZS) appointed Leslie Auld as SVP and CFO, succeeding James Clavijo, who is leaving the company to pursue other interests.
A chartered accountant, Ms. Auld has more than 25 years of accounting, finance and pharmaceutical industry experience, with increasingly senior roles at PricewaterhouseCoopers, Helix BioPharma, Luminex Diagnostics, Attwell Capital and GeneNews.
"We are thankful to James for the important role he played with us while we implemented the first stage of our licensing arrangements with Strongbridge Biopharma," Michael Ward, president and CEO of Aeterna, said in a statement.
"Now, having successfully launched Macrilen this summer, we are excited to have been able to attract someone as accomplished and experienced as Leslie to our senior executive team," he added.